Treatment of breakthrough pain by drug aerosol inhalation

Details for Australian Patent Application No. 2004305518 (hide)

Owner Alexza Molecular Delivery Corporation

Inventors Wensley, Martin J.; Rabinowitz, Joshua D.; Shen, William W.

Agent Davies Collison Cave

Pub. Number AU-A-2004305518

PCT Pub. Number WO2005/061033

Priority 60/530,058 16.12.03 US

Filing date 23 November 2004

Wipo publication date 7 July 2005

International Classifications

A61M 15/00 (2006.01) Inhaling devices

A61M 11/04 (2006.01) Sprayers

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/061033 Priority application(s): WO2005/061033

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305525-Method, apparatus, and program product for detecting money laundering activities in gaming systems

2004305517-Flush syringe having anti-reflux stopper